The new independent director will take seats on three key board committees as the skin-health company presses ahead with its Transform & Transcend growth plan.

May 1, 2026

Solésence, Inc., the Romeoville, Illinois-based developer of mineral-based skin and sun protection technologies, has broadened its boardroom with the addition of an independent director the company expects will help guide it through its next phase of growth.

The Nasdaq-listed firm, which trades under the ticker SLSN, announced on April 27 that Marc James had joined its Board of Directors with immediate effect. Alongside the appointment, the board placed James on three of its central oversight bodies:

• Audit Committee
• Compensation Committee
• Nominating Committee

Leadership endorsement

President and Chief Executive Officer Kevin Cureton welcomed the move, pointing to James’s leadership background, strategic acumen, and capital markets expertise as qualities that should benefit Solésence as it scales operations, deepens partnerships with brand customers, and continues executing on its growth plans. Cureton suggested that James’s perspective would be a meaningful asset to both directors and shareholders.

Board Chair Janet Whitmore characterized the move as broadening the directors’ collective expertise and said she looked forward to James’s contributions across all three committees. She tied the appointment to the company’s continued focus on disciplined execution, operational excellence, and sustainable, profitable growth.

A capital markets background

James has built his career across the global financial markets, holding senior managing director positions in which he counseled corporate clients on capital markets activity, interest rate risk management, and financing strategy. That blend of finance, strategy, and governance experience, the company indicated, makes him well-suited to support Solésence as it advances its Transform & Transcend strategic initiative.

In comments accompanying the announcement, James described his arrival as coming at an exciting period for Solésence. He noted that the company has carved out a distinctive position spanning beauty, skin health, and innovation, and signaled that he would aim to work alongside management and his fellow directors to build on existing momentum and generate lasting shareholder value.

Company context

Solésence positions itself as a leader in scientifically-driven health care products serving the beauty and life science markets. Its mineral-based sun protection technologies are engineered to combine transparency, effectiveness, and wearability, and the company supplies formulations to partner brands that integrate protection, prevention, and treatment features into everyday consumer products.

The appointment marks the latest corporate-governance development at Solésence, which submitted its most recent annual report on March 31, 2026.